|
⚲
|
| Keyboard |
| Prendergast Franklyn G
✚
|
|
|---|---|
| CIK # | 0001233256 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001233256] | |
| 4 | [0001233256] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Prendergast Franklyn G | |
| Immunome Inc | |
| Ohr Pharmaceutical Inc | |
| Lantern Pharma | |
| Cancer Genetics Inc | |
| Lilly Eli & Co |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Immunome Inc IMNM
Common Stock
|
2023-10-02 | Grant | 60,840 | $0.00 | |
|
Immunome Inc IMNM
Stock Option (Right to Buy) · derivative
|
2023-10-02 | Grant | 137,725 | $1.35 | 185,929 |
|
Immunome Inc IMNM
Stock Option (Right to Buy) · derivative
|
2023-06-08 | Grant | 6,500 | $0.00 | |
|
Ohr Pharmaceutical Inc NBSE
Stock option (right to buy) · derivative
|
2022-09-09 | Grant | 37,600 | $0.00 | |
|
Immunome Inc IMNM
Stock Option (Right to Buy) · derivative
|
2022-06-16 | Grant | 6,500 | $0.00 | |
|
Lantern Pharma LTRN
Stock Option (Right to Buy) · derivative
|
2021-11-04 | Grant | 3,200 | $0.00 | |
|
Ohr Pharmaceutical Inc NBSE
Stock option (right to buy) · derivative
|
2021-08-19 | Grant | 38,135 | $0.00 | |
|
Immunome Inc IMNM
Stock Option (Right to Buy) · derivative
|
2021-06-16 | Grant | 7,500 | $0.00 | |
|
Ohr Pharmaceutical Inc NBSE
Stock option (right to buy) · derivative
|
2020-09-09 | Grant | 14,634 | $0.00 | |
|
Lantern Pharma LTRN
Stock Option · derivative
|
2020-06-15 | Grant | 9,135 | ||
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2019-07-23 | Grant | 100,000 | $0.00 | |
|
Ohr Pharmaceutical Inc NBSE
Stock option (right to buy) · derivative
|
2019-07-12 | Grant | 227,330 | $0.00 | |
|
Lilly Eli & Co LLY
Common Stock
|
2017-11-20 | Grant | 802 | $83.18 | 66,710 |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2017-09-28 | Grant | 5,000 | $0.00 | |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2017-09-28 | Grant | 2,500 | $0.00 | |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2017-06-07 | Grant | 2,500 | $0.00 | |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2017-06-07 | Grant | 10,000 | $0.00 | |
|
Lilly Eli & Co LLY
Common Stock
|
2016-11-30 | Grant | 2,088 | $76.64 | 160,024 |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2016-10-11 | Grant | 2,500 | $0.00 | |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2016-10-11 | Grant | 10,000 | $0.00 | |
| showing 20 of 27 most recent transactions | |||||